<DOC>
	<DOCNO>NCT00739037</DOCNO>
	<brief_summary>The primary purpose study assess biomarker know amyloid beta peptide 40 ( Ab40 ) Cerebrospinal Fluid ( CSF ) , follow single oral dose PAZ-417 subject Alzheimer Disease ( AD ) . This study also consider another biomarker amyloid beta peptide 42 ( Ab42 ) Cerebrospinal Fluid subject Alzheimer Disease ass safety , tolerability pharmacokinetic profile PAZ-417 plasma Cerebrospinal Fluid subject .</brief_summary>
	<brief_title>Study Evaluating PAZ-417 Cerebrospinal Fluid Subjects With Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Inclusion : 1 . Men woman nonchildbearing potential , 55 year age old probable diagnosis Alzheimer 's Disease ( AD ) , accord National Institute Neurological Communicative Disorders StrokeAlzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) criterion . Subjects AD mild moderate severity , qualify score 12 26 MiniMental State Examination ( MMSE ) . Woman nonchildbearing potential must either surgically sterile ( hysterectomy and/or oophorectomy ) postmenopausal least 1 year must negative serum pregnancy test result within 48 hour administration test article . Sexually active men must agree use medically acceptable form contraception study continue 12 week test article administration . 2 . Body mass index range 18 32 kg/m2 body weight great equal 50 kg . 3 . Subjects must generally healthy , exception AD may enrol stable , chronic illness , well control interfere primary objective study . Subjects may include clinically important deviation normal limit medical history , physical examination finding , vital sign measurement , finding 12 lead electrocardiogram ( ECG ) , chronic laboratory test result associate stable , well control chronic illness . Exclusion : 1 . Any surgical medical condition may interfere absorption , distribution , metabolism , excretion test article . 2 . Any significant unstable uncontrolled cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , psychiatric disease . 3 . History vascular disorder ( peripheral , coronary , venous ) , chronic inflammatory disorder ( eg , rheumatoid arthritis ) , hematologic disorder , bleed disorder ( eg , hemophilia , idiopathic thrombocytopenic purpura , VonWillebrand disease ) . 4 . History thrombotic event . 5 . Presence history symptomatic vertigo , significant cardiac valvular disease , congestive heart failure , angina pectoris , significant cardiac arrhythmia , seizure .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>